{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:05:15Z","timestamp":1785215115051,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2003\/14008-9"],"award-info":[{"award-number":["2003\/14008-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2010\/20002-0"],"award-info":[{"award-number":["2010\/20002-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["05\/59142-2"],"award-info":[{"award-number":["05\/59142-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2008\/03232-1"],"award-info":[{"award-number":["2008\/03232-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2008\/57889-1"],"award-info":[{"award-number":["2008\/57889-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["573799\/2008-3"],"award-info":[{"award-number":["573799\/2008-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["573799\/2008-3"],"award-info":[{"award-number":["573799\/2008-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["480552-2011"],"award-info":[{"award-number":["480552-2011"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4392-8","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T11:17:24Z","timestamp":1524827844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0636-2558","authenticated-orcid":false,"given":"Tatiana","family":"Rabachini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Boccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubiana","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia Regina","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suely","family":"Nonogaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda Midea","family":"Cuccovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Lina","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"issue":"1","key":"4392_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ijc.1571","volume":"97","author":"P Pisani","year":"2002","unstructured":"Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97(1):72\u201381.","journal-title":"Int J Cancer"},{"issue":"1","key":"4392_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"issue":"19","key":"4392_CR3","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1056\/NEJMoa065497","volume":"356","author":"G D'Souza","year":"2007","unstructured":"D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944\u201356.","journal-title":"N Engl J Med"},{"issue":"6","key":"4392_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/jnci\/djn025","volume":"100","author":"ML Gillison","year":"2008","unstructured":"Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100(6):407\u201320.","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 2","key":"4392_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S1201-9712(07)60015-0","volume":"11","author":"J Paavonen","year":"2007","unstructured":"Paavonen J. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias. Int J Infect Dis. 2007;11(Suppl 2):S3\u20139.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"4392_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","volume":"88","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88(1):63\u201373.","journal-title":"Br J Cancer"},{"issue":"12","key":"4392_CR7","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1002\/j.1460-2075.1989.tb08570.x","volume":"8","author":"P Hawley-Nelson","year":"1989","unstructured":"Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 1989;8(12):3905\u201310.","journal-title":"EMBO J"},{"issue":"3","key":"4392_CR8","first-page":"673","volume":"138","author":"RA Blanton","year":"1991","unstructured":"Blanton RA, Perez-Reyes N, Merrick DT, McDougall JK. Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. Am J Pathol. 1991;138(3):673\u201385.","journal-title":"Am J Pathol"},{"issue":"6","key":"4392_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63(6):1129\u201336.","journal-title":"Cell"},{"issue":"20","key":"4392_CR10","first-page":"4620","volume":"56","author":"SN Boyer","year":"1996","unstructured":"Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996;56(20):4620\u20134.","journal-title":"Cancer Res"},{"issue":"2","key":"4392_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/rmv.488","volume":"16","author":"CM Hebner","year":"2006","unstructured":"Hebner CM, Laimins LA. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol. 2006;16(2):83\u201397.","journal-title":"Rev Med Virol"},{"issue":"4","key":"4392_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro1855","volume":"6","author":"NJ Buchkovich","year":"2008","unstructured":"Buchkovich NJ, Yu Y, Zampieri CA, Alwine JC. The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway. Nat Rev Microbiol. 2008;6(4):266\u201375.","journal-title":"Nat Rev Microbiol"},{"key":"4392_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12943-015-0361-x","volume":"14","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wu J, Ling MT, Zhao L, Zhao KN. The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer. 2015;14:87.","journal-title":"Mol Cancer"},{"issue":"5548","key":"4392_CR14","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1126\/science.1066015","volume":"294","author":"Y Fang","year":"2001","unstructured":"Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Sci. 2001;294(5548):1942\u20135.","journal-title":"Sci"},{"issue":"20","key":"4392_CR15","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.4161\/cc.7.20.6881","volume":"7","author":"Y Sun","year":"2008","unstructured":"Sun Y, Chen J. mTOR signaling: PLD takes center stage. Cell Cycle. 2008;7(20):3118\u201323.","journal-title":"Cell Cycle"},{"issue":"3","key":"4392_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.201107033","volume":"195","author":"MS Yoon","year":"2011","unstructured":"Yoon MS, Du G, Backer JM, Frohman MA, Chen J. Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway. J Cell Biol. 2011;195(3):435\u201347.","journal-title":"J Cell Biol"},{"issue":"3","key":"4392_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.molcel.2015.03.028","volume":"58","author":"MS Yoon","year":"2015","unstructured":"Yoon MS, Rosenberger CL, Wu C, Truong N, Sweedler JV, Chen J. Rapid mitogenic regulation of the mTORC1 inhibitor, DEPTOR, by phosphatidic acid. Mol Cell. 2015;58(3):549\u201356.","journal-title":"Mol Cell"},{"issue":"25","key":"4392_CR18","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1038\/sj.onc.1206565","volume":"22","author":"Y Chen","year":"2003","unstructured":"Chen Y, Zheng Y, Foster DA. Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene. 2003;22(25):3937\u201342.","journal-title":"Oncogene"},{"issue":"6","key":"4392_CR19","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1128\/MCB.00782-08","volume":"29","author":"A Toschi","year":"2009","unstructured":"Toschi A, Lee E, Xu L, Garcia A, Gadir N, Foster DA. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol Cell Biol. 2009;29(6):1411\u201320.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4392_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/0008-5472.CAN-06-3016","volume":"67","author":"DA Foster","year":"2007","unstructured":"Foster DA. Regulation of mTOR by phosphatidic acid? Cancer Res. 2007;67(1):1\u20134.","journal-title":"Cancer Res"},{"issue":"4","key":"4392_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/carcin\/20.4.569","volume":"20","author":"EM Jung","year":"1999","unstructured":"Jung EM, Betancourt-Calle S, Mann-Blakeney R, Griner RD, Bollinger Bollag W. Sustained phospholipase D activation is associated with keratinocyte differentiation. Carcinogenesis. 1999;20(4):569\u201376.","journal-title":"Carcinogenesis"},{"issue":"2","key":"4392_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.virol.2008.10.006","volume":"384","author":"ME McLaughlin-Drubin","year":"2009","unstructured":"McLaughlin-Drubin ME, M\u00fcnger K. The human papillomavirus E7 Oncoprotein. Virology. 2009;384(2):335\u201344.","journal-title":"Virology"},{"issue":"11","key":"4392_CR23","first-page":"789","volume":"1","author":"DA Foster","year":"2003","unstructured":"Foster DA, Xu L. Phospholipase D in cell proliferation and cancer. Mol Cancer Res. 2003;1(11):789\u2013800.","journal-title":"Mol Cancer Res"},{"key":"4392_CR24","doi-asserted-by":"publisher","unstructured":"Helt AM, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis. 2003;24(2):159\u201369. https:\/\/doi.org\/10.1093\/carcin\/24.2.159 .","DOI":"10.1093\/carcin\/24.2.159"},{"issue":"10","key":"4392_CR25","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1128\/JVI.70.10.6862-6869.1996","volume":"70","author":"GW Demers","year":"1996","unstructured":"Demers GW, Espling E, Harry JB, Etscheid BG, Galloway DA. Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J Virol. 1996;70(10):6862\u20139.","journal-title":"J Virol"},{"issue":"15","key":"4392_CR26","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.1128\/JVI.75.15.6737-6747.2001","volume":"75","author":"AM Helt","year":"2001","unstructured":"Helt AM, Galloway DA. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J Virol. 2001;75(15):6737\u201347.","journal-title":"J Virol"},{"issue":"56","key":"4392_CR27","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1038\/sj.onc.1204091","volume":"19","author":"M Hidalgo","year":"2000","unstructured":"Hidalgo M, Rowinsky EK. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene. 2000;19(56):6680\u20136.","journal-title":"Oncogene"},{"issue":"11","key":"4392_CR28","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1158\/0008-5472.CAN-06-0499","volume":"66","author":"CW Menges","year":"2006","unstructured":"Menges CW, Baglia LA, Lapoint R, McCance DJ. Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res. 2006;66(11):5555\u20139.","journal-title":"Cancer Res"},{"key":"4392_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/nar\/28.1.316","volume":"28","author":"E Wingender","year":"2000","unstructured":"Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, Meinhardt T, Pr\u00fcss M, Reuter I, Schacherer F. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res. 2000;28:316\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"4392_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/sj.bjc.6603353","volume":"95","author":"RT Kurmasheva","year":"2006","unstructured":"Kurmasheva RT, Huang S, Houghton PJ. Predicted mechanisms of resistance to mTOR inhibitors. Br J Cancer. 2006;95(8):955\u201360.","journal-title":"Br J Cancer"},{"issue":"25","key":"4392_CR31","doi-asserted-by":"publisher","first-page":"22522","DOI":"10.1074\/jbc.M010505200","volume":"276","author":"JR Basile","year":"2001","unstructured":"Basile JR, Zacny V, Munger K. The cytokines tumor necrosis factor-alpha (TNF-alpha ) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein. J Biol Chem. 2001;276(25):22522\u20138.","journal-title":"J Biol Chem"},{"issue":"2","key":"4392_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.virol.2004.07.026","volume":"328","author":"E Boccardo","year":"2004","unstructured":"Boccardo E, Noya F, Broker TR, Chow LT, Villa LL. HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes. Virology. 2004;328(2):233\u201343.","journal-title":"Virology"},{"issue":"3","key":"4392_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/carcin\/bgp333","volume":"31","author":"E Boccardo","year":"2010","unstructured":"Boccardo E, Manzini Baldi CV, Carvalho AF, Rabachini T, Torres C, et al. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha. Carcinogenesis. 2010;31(3):521\u201331.","journal-title":"Carcinogenesis"},{"issue":"12","key":"4392_CR34","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/1940-6207.CAPR-10-0228","volume":"3","author":"MK Stelzer","year":"2010","unstructured":"Stelzer MK, Pitot HC, Liem A, Lee D, Kennedy GD, Lambert PF. Rapamycin inhibits anal carcinogenesis in two preclinical animal models. Cancer Prev Res (Phila). 2010;3(12):1542\u201351.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"4392_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li J, Kim SG, Blenis J. Rapamycin: one drug, many effects. Cell Metab. 2014;19(3):373\u20139.","journal-title":"Cell Metab"},{"issue":"17","key":"4392_CR36","doi-asserted-by":"publisher","first-page":"24228","DOI":"10.18632\/oncotarget.8286","volume":"7","author":"JD Coppock","year":"2016","unstructured":"Coppock JD, Vermeer PD, Vermeer DW, Lee KM, Miskimins WK, et al. mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC. Oncotarget. 2016;7(17):24228\u201341.","journal-title":"Oncotarget"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4392-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4392-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4392-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T09:54:29Z","timestamp":1604224469000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4392-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4392"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4392-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"28 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"485"}}